<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For treatment of steroid-resistant severe <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, a murine monoclonal antibody (25.3) against the alpha chain (CD11a) of the lymphocyte function-associated antigen 1 (LFA-1) was infused into a patient with posthepatitic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who had undergone allogeneic bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>The monoclonal antibody infusion was well tolerated and resulted in appreciable improvement in symptoms of gastrointestinal illness such as <z:hpo ids='HP_0002014'>diarrhea</z:hpo> and <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, suggesting that this antibody may be useful for controlling severe <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> </plain></SENT>
</text></document>